Диссертация (1139535), страница 53
Текст из файла (страница 53)
MedSci Monit. 2013 Jun 5;19:430-7.192. Laskowska M, Leszczyńska-Gorzelak B, Laskowska K, Oleszczuk J.Evaluation of maternal and umbilical serum TNFalpha levels in preeclampticpregnancies in the intrauterine normal and growth-restricted fetus. J Matern FetalNeonatal Med. 2006 Jun;19(6):347-51.193. Lazdam M., Davis E.F., Lewandowski A.J., Worton S.A. et al. Prevention ofVascular Dysfunction after Preeclampsia: A Potential Long-Term OutcomeMeasure and an Emerging Goal for Treatment.
J Pregnancy. 2012;2012:704146.330194. Leal AM, Poon LCY, Frisova V, Venduta A, Nicolaides KH. First-trimestermaternal serum tumor necrosis factor receptor-1and pre-eclampsia. UltrasoundObstet Gynecol. 2009;33:135–141.195. Leanos-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R,Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A. Changes in circulatingconcentrations of soluble fms-like tyrosine kinase-1and placental growth factormeasured by automated electrochemiluminescence immunoassays methods arepredictors of preeclampsia. J Hypertens.
2012;30:2173–2181.196. Levine RJ, Qian C, Leshane ES, Yu KF, England LJ, Schisterman EF,Wataganara T, Romero R, Bianchi DW. Two-stage elevation of cell-free fetalDNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol.2004;190:707–713.197. Li P., Guo W., Du L., Zhao J., Wang Y., Liu L., Hu Y., Hou Y.
MicroRNA29b contributes to pre-eclampsia through its effects on apoptosis, invasion andangiogenesis of trophoblast cells. Clin. Sci. 2013;124:27–40.198. Lie R.T., Rasmussen S., Brunborg H., Gjessing H.K., Lie-Nielsen E., IrgensL.M. Fetal and maternal contributions to risk of preeclampsia: a population basedstudy. Br. Med. J. 1998;316:1343–1347.199. Lim JH, Kim SY, Park SY, Lee MH, Yang JH, Kim MY, Chung JH, LeeSW, Ryu HM. Soluble endoglin and transforming growth factor-beta1in womenwho subsequently developed preeclampsia.
Prenat Diagn. 2009;29:471–476200. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors andoutcomes associated with early- versus late-onset disease. Am J Obstet Gynecol.2013 Dec;209(6):544.e1-544.e12.201. Lisonkova S, Sabr Y, Mayer C, Young C, Skoll A, Joseph KS. Maternalmorbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol.2014 Oct;124(4):771-81.202. Liu S, Joseph KS, Liston RM, Bartholomew S, Walker M, León JA, KirbyRS, Sauve R, Kramer MS; Maternal Health Study Group of Canadian PerinatalSurveillance System (Public Health Agency of Canada). Incidence, Risk Factors,331and Associated Complications of Eclampsia.
Obstet Gynecol. 2011 Nov; 118(5):987-94.203. Liu W.Y., Wang Z.B., Zhang L.C., Wei X., Li L. Tight junction in bloodbrain barrier: an overview of structure, regulation, and regulator substances. CNSNeurosci. Ther. 2012; 18: 609–615.204. Loureiro R, Leite CC, Kahhale S, Freire S, Sousa B, Cardoso EF, Alves EA,Borba P, Cerri GG, Zugaib M. Diffusion imaging may predict reversible brainlesions in eclampsia and severe preeclampsia: initial experience.
Am J ObstetGynecol. 2003 Nov;189(5):1350-5.205. Luksha L, Nisell H, Luksha N, Kublickas M, Hultenby K, Kublickiene K.Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneouscontribution, mechanisms, and morphological prerequisites. Am J Physiol RegulIntegr Comp Physiol. 2008; 294: R510–R519.206. Luo L., Ye G., Nadeem L., Fu G., Yang B.B., Honarparvar E., Dunk C., LyeS., Peng C. MicroRNA-378a-5p promotes trophoblast cell survival, migration andinvasion by targeting Nodal. J.
Cell Sci. 2012;125:3124–3132.207. Lv H, Wang Q, Wu S, Yang L, Ren P, Yang Y, Gao J, Li L. Neonatalhypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinalfluid. Clin Chim Acta. 2015 Oct 23;450:282-97.208. Lynch AM, Murphy JR, Gibbs RS, et al. The interrelationship ofcomplement-activation fragments and angiogenesis-related factors in earlypregnancy and their association with pre-eclampsia. British Journal of Obstetricsand Gynaecology. 2010;117(4):456–462.209. MacKay A.P., Berg C.J., Atrash H. K. Pregnancy-related mortality frompreeclampsia and eclampsia. Obstet Gynecol. 2001; 97: 533–538.210. Magee LA, Yong PJ, Espinosa V, Côté AM, Chen I, von Dadelszen P.Expectant management of severe preeclampsia remote from term: a structuredsystematic review.
Hypertens Pregnancy. 2009;28(3):312-47.211. Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE,Himes NC, Matharu KS, Karumanchi SA, D'Amore PA. VEGF and TGF-beta are332required for the maintenance of the choroid plexus and ependyma. J Exp Med.2008 Feb 18;205(2):491-501.212. Major HD, Campbell RA, Silver RM, Branch DW, Weyrich AS.
Synthesisof sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis ofpreeclampsia. Am J Obstet Gynecol. 2014 Jun;210(6):547.213. MakridesM,CrosbyDD,BainE,CrowtherCA.Magnesiumsupplementation in pregnancy. Cochrane Database Syst Rev. 2014 Apr3;4:CD000937.214. Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, WaughR, McKenzie P, Kirwan P, Hennessy A. Uteroplacental ischemia results inproteinuric hypertension and elevated sFLT-1. Kidney Int 2007; 71: 977–984.215. Many A, Fatta lA, Leitner Y, Kupferminc MJ, Hare lS, Jaffa A.Neurodevelopmental and cognitive assessment of children born growth restrictedto mothers with and without preeclampsia. Hypertens Pregnancy. 2003;22:25–29.216. Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening forpre-eclampsia and fetal growth restriction by uterine arteryDoppler at 11–14 weeksof gestation.
Ultrasound Obstet Gynecol. 2001;18:583–586.217. Martin JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Strokeand severe preeclampsia and eclampsia: a paradigm shift focusing on systolicblood pressure. Obstet Gynecol. 2005 Feb;105(2):246-54.218. Martinelli I, Ruggenenti P, Cetin I, Pardi G, Perna A, Vergani P, Acaia B,Facchinetti F, La Sala GB, Bozzo M, Rampello S, Marozio L, Diadei O, GherardiG, Carminati S, Remuzzi G, Mannucci PM. Heparin in pregnant women withprevious placenta-mediated pregnancy complications: a prospective, randomized,multicenter, controlled clinical trial. Blood.
2012 Apr 5;119(14):3269-75.219. Marusic J, Prusac IK, Tomas SZ, Karara JR, Roje D. Expression ofinflammatory cytokines in placentas from pregnancies complicated withpreeclampsia and HELLP syndrome. J Matern Fetal Neonatal Med. 2013May;26(7):680-5.333220. Maynard S, Epstein FH, Karumanchi SA. Preeclampsia and angiogenicimbalance. Annu Rev Med. 2008;59:61-78.221. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excessplacental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelialdysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest.2003;111:649–658.222. Mayor-Lynn K., Toloubeydokhti T., Cruz A.C., Chegini N. Expressionprofile of microRNAs and mRNAs in human placentas from pregnanciescomplicated by preeclampsia and preterm labor.
Reprod. Sci. 2011;18:46–56.223. McCowan LM, North RA, Kho EM, Black MA, Chan EH, Dekker GA,Poston L, Taylor RS, Roberts CT. Paternal contribution to small for gestational agebabies: a multicenter prospective study. Obesity (Silver Spring) 2011; 19(5): 10359.224.McDonald SD, Lutsiv O, Dzaja N, Duley L. A systematic review ofmaternalandinfantoutcomesfollowingmagnesiumsulfateforpre-eclampsia/eclampsia in real-world use. Int J Gynaecol Obstet.
2012 Aug; 118(2):90-6.225. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. Astudy of placental bed spiral arteries and trophoblast invasion in normal and severepre-eclamptic pregnancies. Br J Obstet Gynaecol. 1994; 101: 669–674.226. Mirza A. Posterior reversible encephalopathy syndrome: a variant ofhypertensive encephalopathy. J Clin Neurosci. 2006 Jun;13(5):590-5.227.
Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002;2(9): 656-63.228. Mori T, Watanabe K, Iwasaki A, Kimura C, Matsushita H, Shinohara K,Wakatsuki A. Differences in vascular reactivity between pregnant women withchronic hypertension and preeclampsia. Hypertens Res. 2014 Feb;37(2):145-50.229.
Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM.Effectiveness-based guidelines for the prevention of cardiovascular disease in334women - 2011 update: a guideline from the american heart association. Circulation.2011 Mar 22;123(11):1243-62.230. Mouillet J.F., Chu T., Sadovsky Y. Expression patterns of placentalmicroRNAs. Birth Defects Res. A. 2011;91:737–743.231. Mouillet JF, Chu T, Nelson DM, Mishima T, Sadovsky Y. MiR-205 silencesMED1 in hypoxic primary human trophoblasts. FASEB J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
